News Articles

In an amazing update for the ALS community, on September 29, 2022, the FDA voted to approve ALS drug AMX0035 for the treatment of ALS. This comes a year after Amylyx, a Massachusetts-based pharmaceutical company, submitted a New Drug Application (NDA) for AMX0035, a...

On December 23, 2021, we reached a groundbreaking milestone for the ALS community. President Joe Biden has just signed the Access to Critical Therapies (ACT) for ALS Act into law. The Senate voted unanimously to pass the Act on December 16, with it previously passing...

This year, we are serving more Texans with ALS than ever before. This number has especially grown the past two years, and is a strong indicator of our connection with the ALS community here in Texas. But what does this number of people served actually mean? The...

This year, our ALS community continued to work together to serve Texans with ALS and their families. It’s been a year of constant change, but your commitment never wavered. And because of you, we are serving more Texans with ALS and their families than ever before....